title: Results of a customer-based, post-market surveillance survey of the HeRO access device.
abstract: In order to supplement post-market surveillance data on the HeRO vascular access device, a non-scientific customer survey was conducted to obtain quantitative data from dialysis providers caring for patients implanted with the device. Dialysis nurses involved in the care of HeRO patients were contacted in order to obtain post-implant device performance information for 10% of patients implanted with the device at the time of the survey. Thirty-eight dialysis units with a total of 65 HeRO patients participated in the survey. The total duration of HeRO device use was 348.4 months with an average use of 5.4 months. Thirty-eight of the 65 HeRO patients (58.5%) were reported to not have experienced any performance issues. There were 28 device performance incidents reported for the remaining 27 patients included in the survey. Occlusion was the single most commonly reported device-related performance issue with 18 patients (27.7%) experiencing 25 occlusive episodes. The majority of the patients who had an occlusion (66.7%) only experienced one occlusive event. Infections occurred in 4 patients (6.2%) with an overall infection rate of 0.38 per 1,000 patient days. Post-market clinical experience during the first 18 months of commercialization of the HeRO device were in line with expectations based on the results from initial clinical studies with the device. Device occlusion remains the most commonly reported performance issue with the reported rate in this survey less than that which was reported in earlier published studies with the device.
authors.affiliation: Hemosphere, Inc., Eden Prairie, MN, USA.
authors.forename: Maureen
authors.initials: M
authors.lastname: Fusselman
mesh_terms: D002408:Catheters, Indwelling / Q000592:standards*; D003625:Data Collection / Q000379:methods*; D020878:Device Removal / Q000379:methods; D004867:Equipment Design; D006801:Humans; D040541:Marketing / Q000379:methods*